Loading…
Loading…
Leclanché SA is a Swiss lithium-ion battery cell and systems manufacturer headquartered in Yverdon-les-Bains, with automated cell production in Willstätt, Germany.
GLEIF has no LEI record for 'Leclanché SA' (CH). A search for 'Leclanché' returns only an unrelated Belgian entity, LEI 967600249Z1PE3QS8K14, status LAPSED, no relationship data — not usable. No corporate parent: Leclanché is independently listed (SIX: LECN, suspended from trading since 1-Jun-2026 pending its 2025 annual report) and controlled by a fund group, not a company in this corpus. FEFAM (Finexis Equity Fund Asset Management) has been named Leclanché's largest/main shareholder in company press releases since at least 2019 and again in 2025 AGM materials; the company's recurring debt-to-equity conversions (most recently CHF 40.06m, Dec-2025) are described by Leclanché itself as reflecting its 'majority shareholder's steadfast commitment' but the release does not name the shareholder or a current stake percentage. A 2023-vintage secondary aggregator (Simply Wall St via Yahoo Finance) cites Finexis S.A. at 46%, but that figure predates the 2025-26 dilutive conversions and is not used here as current.
Named counterparties identified by open-source research and written only where a primary source states the relationship — never inferred from sector or co-mention. 1 customer-side. This is a partial view: it covers the relationships we could evidence, not the company's full supply base.
Leclanche supplies two Navius MRS-3 1.1 MWh battery systems (contracted 2023-04-04, via integrator elkon/SCHOTTEL Group at CEMRE shipyard, Turkey) for twin CMAL RoPax hybrid ferries serving Islay and Jura, Scotland; CMAL (Scottish state-owned ferry-asset company) also ordered a second pair of hybrid ferries with Leclanche battery systems for the Outer Hebrides.
Scope. Absence of a counterparty here is not evidence that none exists — most commercial sourcing is confidential and never becomes public. Rows without a share figure mean no share was disclosed, not that the relationship is small.
Every exposure is read as a buyer dependency; the top 3 are its binding chokepoints.
As a buyer, policy pressure across its consumed materials is flat.
Descriptive trend in official policy actions on this company’s materials — a policy-pressure trend, not a price or trading signal. No forward probability is implied. Direction is measured on actions we have discovered, and discovery lags events: where the recent window is too thin to support a calm reading, the row says coverage-limited instead of easing.
🇪🇺 EU accounts for 100% of severity-weighted pressure.